Functional antagonism between IL-2 and PGA1 or PGJ2 in the control of proliferation of human cord blood-derived mononuclear cells

International Journal of Immunopharmacology

Volumn 18, Issue 11, 1996, Pages 609-617

  Franzese, Ornella ^a   Bonmassar, Enzo ^a,b   Marcucci, Aurelio ^b   D'Onofrio, Chiara ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SANTA MARIA GORETTI HOSPITAL   (Italy)

Author keywords

Accessory cells; ACs; CBMCs; Cord blood mononuclear cells; IL 2 R ; Interleukin 2 receptor

Indexed keywords

CYCLIN A; DNA FRAGMENT; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROSTACYCLIN; PROSTAGLANDIN A1;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GROWTH DISORDER; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR DOWN REGULATION; RNA SYNTHESIS; UMBILICAL CORD BLOOD;

EID: 0030292191     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(96)00072-0     Document Type: Article

References (43)

1. Ankel, H., Turriziani, O. & Antonelli, G. (1991) Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection. J. Gen. Virol., 72, 2797-2800.
2. Bregman, M. D., Funk, C. & Fukushima, M. (1986) Inhibition of human melanoma growth by prostaglandin A D, and J analogues. Cancer Res., 46, 2740-2744.
3. Carding, S. R., Hayday, A. C. & Bottomly, K. (1991) Cytokines in T-cell development. Immun. Today, 12, 239-245.
4. Colotta, F., Polentarutti, N., Sironi, M. & Mantovani. A. (1992) Expression and involvement of c-fos and c-jun proto-oncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem., 267, 18278-18283.
5. D'Onofrio, C., Alvino, E., Garaci, E., Bonmassar, E. & Santoro, M. G. (1990a) Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures. Br. J. Cancer, 61, 207-214.
6. 2 against the HTLV-I positive, chronically infected MT-2 cells. Int. J. Cancer, 51, 481-488.
7. D'Onofrio, C., Franzese, O., De Marco, A., Bonmassar, E., Amici, C. (1994) Control of proliferation of HTLV-I infected mononuclear cells by cyclopentenone prostaglandins is independent of IL-2 autocrine regulation and is associated with HSP 70 induction. Leukemia, 8, 1045-1056.
8. D'Onofrio, C., Perno, C. F., Mazzetti, P., Graziani, G., Caliò, R. & Bonmassar, E. (1988) Depression of early phase of HTLV-I infection in vitro mediated by human β-interferon. Br. J. Cancer, 57, 481-488.
9. D'Onofrio, C., Pesce, C. D., Fontana, T., Ciprani, F., Bonmassar, E., Caliò, R. (1990b) Modulation of the cell-mediated immune function by interferon α, β or γ can partially reverse the immunosuppression induced by human T-cell leukemia virus I in cord blood cultures. Cancer Immun. Immunother., 31, 213-220.
10. Depper, J. M., Leonard, W. J., Krönke, M., Noguki, P. D., Cunningham, R. E., Waldmann, T. A. & Greene, W. C. (1984) Regulation of interleukin-2 receptor expression: effects of phorbol diester, phospholipase C, and re-exposure to lectin and antigen. J. Immun., 133, 3054-3061.
11. Dröge, W., Wolf, M. & Mihm, S. (1986). The effect of prostaglandins on the intracellular signal transmission and regulation of T-cell functions. In Prostaglandins in Cancer Research (eds Garaci, E., Paoletti, R. and Santoro, M. G.), p. 216. Springer Verlag, Berlin-Heidelberg.
12. Duke, R. C. & Cohen, J. J. (1986). IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. In Limphokine Research, Vol. 5. pp. 289-298. Mary Ann Liebert Inc. Publishers.
13. Farrar, J. J., Fuller Farrar, J., Simon, P. L., Hilfinker, M. L., Stadler, B. M. & Farrar, W. L. (1980) Thymoma production of T-cell growth factor (interleukin 2). J. Immun., 125, 2555-2558.
14. 2-anti-tumour and antiviral activities and the mechanisms involved. Eicosanoids, 3, 189-199.
15. Herrmann, F., Cannistra, S. A., Lindemann, A., Blohm, D., Rambaldi, A., Mertelsmann, R. H. & Griffin, J. D. (1989) Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1β secretion by IFN and IL-2. J. Immun., 142, 139-143.
16. Hughes-Fulford, M. (1987). The mechanism of prostaglandin inhibition on the cell cycle. In Prostaglandins in Cancer Research (eds Garaci, E., Paoletti, R. and Santoro, M. G.), pp. 115-128. Springer Verlag, Berlin-Heidelberg.
17. Jaffe, B. M., Begrman, J. & Parker, C. W. (1973) Radioimmunoassay measurement of prostaglandins E, A and F in human plasma. J. Clin. Invest., 52, 398-405.
18. Jain, J., Valge-Archer, V. E. & Rao, A. (1992) Analysis of the AP-1 sites in the IL-2 promoter. J. Immun., 148, 1240-1250.
19. Malkovsky, M., Loveland, B., North, M., Asherson, G. L., Gao, L., Ward, P. & Fiers, W. (1987) Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature, 325, 262-265.
20. Manger, B., Weiss, A., Weyand, C., Goronzy, J. & Stobo, J. D. (1985) T-cell activation: differences in the signals required for IL-2 production by nonactivated and activated T-cells. J. Immun., 135, 3669-3673.
21. Minami, Y., Kono, T., Yamada, K. & Tanigichi, T. (1992) The interleukin-2 receptors: insights into a complex signalling mechanism. Biochim. Biophys. Acta, 1114, 163-177.
22. Miyazaki, T., Liu, Z. J., Kawahara, A., Minami, Y., Barsonmian, E. L., Permutter, R. M. & Taniguchi, T. (1995) Three distinct IL-2 signalling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell, 81, 223-231.
23. Motokura, T. & Arnold, A. (1993) Cyclins and oncogenesis. Biochim. Biophys. Acta, 1155, 63-78.
24. Narumiya, S., Fukushima, M. (1986) Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J. Pharmacol. Exp. Ther., 239, 500-505.
25. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Poyak, K., Lee, M. H., Massayne, J., Crabtree, G. R. & Roberts, J. M. (1994) Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372(6506), 570-573.
26. Noyori, R. & Suzuki, M. (1993) Organic synthesis of prostaglandins: advancing biology. Science, 259, 44-45.
27. 1-enriched HeLa S3 cells. J. Pharmacol. Exp. Ther., 245, 294-298.
28. Puglianiello, A., Lanzilli, G., Franzese, O. & D'Onofrio, C. (1993) Antiproliferative activity of cyclopentenone prostaglandins on human leukemic cells. Oncology (Life Sci. Adv.), 12, 1-13.
29. Racadot, E. (1993) Cord blood lymphocyte populations. Immun. Today, 14, 189-190.
30. Roosnek, E. E., Brouwer, M. C., Kipp, B. J. & Aarden, L. A. (1986) Monocyte-dependent induction of proliferation of human peripheral T cells by recombinant interleukin-2. Eur. J. Immun., 16, 35-40.
31. Samuelsson, B. (1982). Prostaglandins, thromboxanes and leukotrienes: biochemical pathways. In Prostaglandins and Cancer: First International Conference (eds Powles, T. J., Bockman, R. S., Honn, K. W. and Ramwell, P.) pp. 1-19. Alan R. Liss Inc., New York.
32. Santoli, D., Phillips, P. D., Colt, T. L., Zurier, R. B. (1990) Suppression of interleukin 2-dependent human T-cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. J. Clin. Invest., 85, 424-432.
33. Santoro, M. G., Bendetto, A., Carruba, G., Garaci, E. & Jaffe, B. M. (1980) Prostaglandin A compound as antiviral agents. Science, 209, 1032-1034.
34. 1. Cancer Res., 46, 6073-6077.
35. Santoro, M. G., Garaci, E. and Amici, C. (1990). Induction of heat shock protein synthesis by prostaglandins with antineoplastic and antiviral activity. In Advanced Prosthetics Tromboxane Leukotriene Research (eds Samuelsson B., Wong P. Y. and Sun F. F.) Vol. 21, pp. 867-874. New York, Raven Press.
36. Santoro, M. G., Garaci, E. & Amici, C. (1989) Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells. Proc. natn. Acad. Sci. U.S.A., 86, 8407-8411.
37. Sikora, E., Grassilli, E., Bellesia, E., Troiano, L., Franceschi, C. (1993) Studies of the relationship between cell proliferation and cell death. AP-1 DNA-binding activity during Concanavalin A-induced proliferation or dexamethazone-induced apoptosis of rat thymocytes. Biochem. Biophys. Res. Commun., 192, 1386-1391.
38. Smith, K. A. (1988) Interleukin 2: inception, impact and implications. Science, 240, 1169-1176.
39. Splowski, J. B., Jelinek, D. F. & Lipsky, P. E. (1991) Delineation of the functional capacity of human neonatal lymphocytes. J. Clin. Invest., 87, 545-553.
40. Taniguchi, T. & Minami, Y. (1993) The IL-2/IL-2 receptor system: a current overview. Cell, 73, 5-8.
41. Toribio, M. L., Gutiérrez-Ramos, J. C., Pezzi, L., Marcos, M. A. R. & Martinez, A. C. (1989) Interleukin-2-dependent autocrine proliferation in T-cell development. Nature, 342, 82-85.
42. Van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herlich, P. & Angel, P. (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J., 14, 1798-1811.
43. Wahl, S. M., McCartney-Francis, N., Hunt, D. A., Smith, P. D., Wahl, L. M. & Katona, I. M. (1987) Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J. Immun., 139, 1342-1347.